Victory Capital Management Inc. Reduces Amgen Inc. Stake

Institutional investor cuts holdings in medical research company by 34.9% in third quarter

Published on Mar. 4, 2026

Got story updates? Submit your updates here. ›

Victory Capital Management Inc., an institutional investor, reduced its holdings in shares of Amgen Inc. (NASDAQ:AMGN) by 34.9% during the third quarter, according to a disclosure filed with the Securities and Exchange Commission. The firm now owns 661,514 shares of the medical research company's stock, valued at $186,679,000.

Why it matters

Amgen is a major player in the biotechnology and pharmaceutical industries, so changes in institutional ownership of its stock can be significant. This reduction in holdings by Victory Capital Management Inc. suggests a shift in investor sentiment or portfolio strategy for the firm.

The details

According to the filing, Victory Capital Management Inc. sold 354,439 shares of Amgen during the third quarter, reducing its total position to 661,514 shares. The firm previously owned 1,015,953 shares of the medical research company's stock.

  • The reduction in holdings occurred during the third quarter of the year.

The players

Victory Capital Management Inc.

An institutional investment management firm that provides investment advisory services.

Amgen Inc.

A global biotechnology company that focuses on discovering, developing, manufacturing, and delivering human therapeutics to address serious illnesses.

Got photos? Submit your photos here. ›

The takeaway

This change in institutional ownership of Amgen stock could signal a shift in investor sentiment or portfolio strategy, which may impact the company's stock price and performance going forward. However, without additional context or commentary from the firm, it's difficult to draw any firm conclusions about the reasons behind the reduction in holdings.